Pancreatic Cancer Research

ResearcherJikei University School of MedicineNo recent work listed

Hisao Tajiri

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5111374672. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2011: 3 papers · 2012: 1 paper · 2013: none · 2014: 4 papers · 2015: 1 paper

Papers 9

  1. Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for p… Last author PMID 25550602↗
  2. Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer. Co-author DOI 10.1097/cji.0000000000000020↗
  3. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer. Last author DOI 10.1158/1078-0432.ccr-14-0314↗
  4. Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis. Last author DOI 10.1179/1973947813y.0000000150↗
  5. Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer. Last author DOI 10.4161/21624011.2014.958950↗
  6. Immunotherapy synergizes with chemotherapy targeting pancreatic cancer. Last author DOI 10.2217/imt.11.150↗
  7. Clinical usefulness of diffusion-weighted MR imaging for detection of pancreatic cancer: comparison with enhanced multidetector-row CT. Last author DOI 10.1007/s00261-011-9728-7↗
  8. Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response. Co-author DOI 10.1007/s00262-011-1033-3↗
  9. Current immunotherapeutic approaches in pancreatic cancer. Last author DOI 10.1155/2011/267539↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigeo Koido · 8 shared papers, 2011–2015 · strength 0.25
  2. Sadamu Homma · 7 shared papers, 2011–2015 · strength 0.21
  3. Kazuki Takakura · 5 shared papers, 2011–2015 · strength 0.18
  4. Haruo Sugiyama · 5 shared papers, 2011–2015 · strength 0.16
  5. Akitaka Takahara · 5 shared papers, 2011–2014 · strength 0.14
  6. Masato Okamoto · 3 shared papers, 2014–2015 · strength 0.11
  7. Mikio Kajihara · 3 shared papers, 2014–2015 · strength 0.11
  8. Shintaro Tsukinaga · 3 shared papers, 2011–2014 · strength 0.09
  9. Shin Kan · 2 shared papers, 2014–2015 · strength 0.07
  10. Yoichi Toyama · 2 shared papers, 2014 · strength 0.06
  11. Sumiyuki Nishida · 2 shared papers, 2011–2014 · strength 0.05
  12. Zensho Ito · 1 shared paper, 2015 · strength 0.04
  13. Kazuki Sumiyama · 1 shared paper, 2011 · strength 0.03
  14. Shigetaka Shimodaira · 1 shared paper, 2014 · strength 0.03
  15. Yuichiro Doki · 1 shared paper, 2014 · strength 0.03
  16. Hidetoshi Eguchi · 1 shared paper, 2014 · strength 0.03
  17. Hiroaki Nagano · 1 shared paper, 2014 · strength 0.03
  18. Yutaka Takeda · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.